Vilanterol

75 interactions 5 explained in plain English

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Hydroxychloroquine Ivabradine Penbutolol Bisoprolol Amisulpride Injection Ofloxacin Otic

74 Major 1 Moderate

All (75) Major (74) Moderate (1)

Major

Vilanterol Goserelin Implant Zoladex Increased risk of QT interval prolongation Details Vilanterol Granisetron Transdermal Patch Sancuso An increased risk of QT interval prolongation Details Vilanterol Granisetron Injection Granisol An increased risk of QT interval prolongation Details Vilanterol Histrelin Implant Supprelin Increased risk of QT interval prolongation Details Vilanterol Hydroxychloroquine Plaquenil Increased risk of QT interval prolongation Details Vilanterol Inotuzumab Ozogamicin Injection Besponsa Increased risk of QT interval prolongation Details Vilanterol Ivabradine Corlanor Increased risk of QT prolongation Details Vilanterol Ketoconazole Topical Extina® Foam Increased risk of QT interval prolongation Details Vilanterol Labetalol Normodyne® Decreased efficacy of vilanterol Details Vilanterol Lefamulin Xenleta Increased risk of QT interval prolongation Details Vilanterol Lenvatinib Lenvima Increased risk of QT-interval prolongation Details Vilanterol Levobunolol Ophthalmic AKBeta® Decreased efficacy of vilanterol Details Vilanterol Levofloxacin Levaquin Increased risk of QT interval prolongation Details Vilanterol Levofloxacin Injection Levaquin Increased risk of QT interval prolongation Details Vilanterol Linezolid Injection Zyvox An increased risk of cardiovascular adverse effects Details Vilanterol Loperamide Diamode An increased risk of QT interval prolongation, which may increase risk of cardiotoxicity (torsade de pointes, cardiac arrest) Details Vilanterol Mefloquine Lariam® An increased risk of QT interval prolongation Details Vilanterol Metronidazole Flagyl An increased risk of QT interval prolongation Details Vilanterol Metronidazole Injection Flagyl An increased risk of QT interval prolongation Details Vilanterol Metronidazole Topical MetroCream® An increased risk of QT interval prolongation Details Vilanterol Metronidazole Vaginal MetroGel® Vaginal An increased risk of QT interval prolongation Details Vilanterol Moxifloxacin Avelox An increased risk of QT interval prolongation Details Vilanterol Moxifloxacin Injection Avelox An increased risk of QT interval prolongation Details Vilanterol Moxifloxacin Ophthalmic Moxeza® An increased risk of QT interval prolongation Details Vilanterol Nadolol Corgard Decreased efficacy of vilanterol Details Vilanterol Nebivolol Bystolic Decreased efficacy of vilanterol Details Vilanterol Octreotide Bynfezia An increased risk of QT interval prolongation Details Vilanterol Octreotide Injection Bynfezia An increased risk of QT interval prolongation Details Vilanterol Ofloxacin Floxin® An increased risk of QT interval prolongation Details Vilanterol Ofloxacin Ophthalmic Ocuflox An increased risk of QT interval prolongation Details Vilanterol Ofloxacin Otic Floxin® Otic An increased risk of QT interval prolongation Details Vilanterol Olodaterol Oral Inhalation Striverdi An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Vilanterol Oxaliplatin Injection Eloxatin® Increased risk of QT-interval prolongation Details Vilanterol Penbutolol Levatol® Decreased efficacy of vilanterol Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.